Medicare AdvantageCoverageMedium impact
MA07.035g, Therapeutic Transcranial Magnetic Stimulation (TMS)
Independence Blue Cross·Psychiatry, Neurology, Pain Management·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated their policy MA07.035g for Therapeutic Transcranial Magnetic Stimulation (TMS) effective January 1, 2026. This is a very recent policy change that may affect coverage criteria, billing requirements, or documentation standards for TMS treatments under Medicare Advantage plans.
Action Required
Before January 1, 2026: Billing team must review the complete MA07.035g policy document at the provided URL to identify specific changes to TMS coverage criteria, prior authorization requirements, or billing procedures. Update billing protocols and staff training accordingly. Contact Medicare Advantage plans to clarify any new requirements that may affect claim processing.